Creating New Networks:

The Eleventh International Symposium on Neurobiology and Neuroendocrinology of Aging / MARK-AGE Summer School 2012

July 29–August 3, 2012, Bregenz, Austria

Programs of Previous Symposia

FIRST INTERNATIONAL SYMPOSIUM, JULY 19–23, 1992.

Speakers:

  • Joseph Meites, Michigan State University, East Landing, USA — Special Lecture: Neuroendocrine interventions that inhibit or reverse aging processes.
  • Herbert Butka, University of Vienna, Austria — Neuropathology of aging and Alzheimer disease.
  • David Bowen, Institute of Neurology and Neurochemistry, London, United Kingdom — Neurotransmitter receptors of ocrtical pyramidal neurons: implications for disorders of the aging human brain.
  • Oleh Hornykiewicz, University of Vienna, Austria — Brain aging and Parkinson disease.
  • Paola Timiras, UC Berkeley, USA — Stress and hormones alter proteins in aging neurons.
  • Phyllis Wise, University of Maryland, Baltimore, USA — Cellular mechanisms and hypothalamic aging.
  • Marco Trabucchi, University of Rome, Italy — Pharmacology of the aging brain.
  • Giancarlo Pepeu, University of Florence, Italy — Central cholinergic systems and aging.
  • Agneta Nordberg, Uppsala University, Sweden — Sexually differentiated expression of cytochrome P450C in rate liver — a model system for studies of GH mechanisms of action.
  • Gad Gilad, NIMH, Washington, DC, USA — Effects of genotype on age related alterations in the stress induced response of central and peripheral neuroendocrine systems.
  • Engenio Müller, University of Milan, Italy — Aspects of the neuroendocrine control of growth hormone secretion.
  • Satya Kalra, University of Florida, USA — Aging of the neuropeptidergic signals.
  • Umberto Scapagnini, University of Catania, Italy — Alteration of hypothalamic function.
  • William Sonntag, Bowman Gray School of Medicine, USA — Significance of changes in growth hormone and insulin-like growth factors in biological aging.
  • Agneta Mode, Karolinska Institute, Sweden — Nicotinic reeptors and aging.
  • Robert Marcus, Stanford University, USA — Effects of growth hormone in the elderly.
  • Luciano Martini, University of Milan, Italy — Aging of the neuroendocrine brain: effects on receptor mechanisms and steroid metabolism.
  • Richard Steger, Southern Illinois University, USA — Premature aging in transgenic mice expressing different growth hormone genes.
  • Luciano Angelucci, University of Rome, Italy — Hyppocampus and behavior.

SECOND INTERNATIONAL SYMPOSIUM, JULY 24–29, 1994.

Speakers:

  • Paola Timiras, UC Berkeley, USA — Special Lecture: Wellness in aging: streee, homeostasis and learning.
  • Leonard Hayflick, UC San Francisco, USA — Cell biology of human longevity: evidence for a telomere clock.
  • Imre Zs. Nagy, University Medical School, Hungary — Semiconduction of proteins as an attribute of the living state.
  • Russel Reiter, University of Texas San Antonio, USA — The neurohormone melatonin: its relation to the pathophysiology of aging.
  • Gilles Pierrefiche, Hospital Boucicaut, France — Melatonin in aging and related diseases: an attempt of integrated approach from behavior to oxygen free radicals.
  • Takayuli Ozawa, University of Nagoya, Japan — Mitochondrial DNA mutations associated with age.
  • Regina Casper, Stanford University, USA — Nutrition and its relationship to aging.
  • Edward Masoro, University of Texas San Antonio, USA — Dietary restriction.
  • Patrick Rabbit, University of Manchester, United Kingdom — Memory changes in normal aging.
  • Donald Caspary, Southern Illinois University, USA — Neurochemical basis of auditory dysfunction with aging.
  • Roger Elble, Southern Illinois University, USA — The role of aging in the clinical expression of essential tremor.
  • Vladimir Frolkis, Institute of Gerontology, Ukraine — Role of "invertors" in the mechanisms of age-related changes of cell response to hormones.
  • C. Kaufmann, Ludwig-Bolzmann Institute, Austria — Integrated psychotherapy in rehabilitation, especially in older age groups.
  • Clarrisa Desjardins, McGill University, Canada — Estadiol-induced hypothalamic beta endorphin neuron loss: a possible model of hypothalamic aging.
  • Michael Meaney, McGill University, Canada — Adrenal stress and aging.
  • Diane Miller, Environmental Protection Agency, USA — Astrogliosis in transgenic mice expressing the bovine growth hormone gene: indication of accelerated aging.
  • Peter Reiderer, University of Würzburg, Germany — Aging of the dopaminergic system.
  • George Roth, NIA-NIH, Baltimore, USA — Changes in tissue responsiveness to hormone and neurotransmitters during aging.
  • Nestor Verkhratsky, Institute of Gerontology, Ukraine — Limbic structures and their influence on endocrine gland function in aged rats.
  • Winfred Rossmaith, University of Ulm, Germany — Gonadotropin secretion during aging in women.
  • James Carey, UC Davis, USA — Sex-specific life table aging rates in large medfly cohorts.
  • Ronald Zec, Southern Illinois University, USA — Neuropsychology of normal human aging.

THIRD INTERNATIONAL SYMPOSIUM, JULY 21–26, 1996.

Speakers:

  • Luciano Martini, University of Milan, Italy — Special Lecture: The brain: a vulnerable target.
  • Geoffrey Bennett, University of Nottingham, United Kingdom — Effect of neuropeptides on cognitive function.
  • Dolores M Catalá, Universidad de Valencia, Spain — Parkinson Disease.
  • Nicola Fabris, INRCA, Italy — Neuroendocrine-immune interaction.
  • Michael O Hengartner, Cold Spring Harbor Laboratory, USA — Aging and apopotosis in the nematode C. elegans.
  • Michel A Hofman, Netherlands Institute for Brain Research, The Netherlands — Lifespan changes in the human hypothalamus.
  • Thomas Kirkwood, University of Manchester, United Kingdom — Network theory of aging.
  • Joseph Knoll, Semmelweis University of Medicine, Hungary — Sexual performance and longevity.
  • S M McCann, Pennington Biomedical Research Center, USA — The nitric oxide hypothesis of brain aging.
  • Arshag D Mooradian, St. Louis University Health Sciences Center, USA — Age-related changes in the blood-brain barrier.
  • Greg Morin, Geron Corporation, USA — Telomere control of replicative lifespan.
  • Hans Nohl, Veterinärmedizinische Universität Wien, Austria — Imbalance of oxygen activation and energy metabolism as a consequence or mediator of aging.
  • Fred Nyberg, University of Uppsala, Sweden — Aging effects on growth hormone receptor binding in the brain.
  • Meinrad Peterlik, University of Vienna, Austria — Aging, neuroendocrine function, and osteoporosis.
  • Walter Pierpaoli, Biancalana-Masera Foundation for the Aged, Switzerland — Circadian melatonin and young to old pineal grafting postpone aging and maintain juvenile conditions of reproductive functions in mice and rats.
  • Yuan Touitou, Faculté de Médecine Pitié-Salpétrière, France — Modification of circadian and circannual rhythms with aging.
  • Eugenia Wang, Bloomfield Center for Research in Aging, Canada — Regulation of apoptosis resistance and ontogeny of age-dependent diseases.
  • Gregg Villeponteau, Geron Corporation, USA — The heterochromatin loss model of aging.
  • George Wick, University of Innsbruck, Austria — The aging immune system: primary and secondary alterations of immune reactivity in the elderly.
  • Barry Zirkin, Johns Hopkins University, USA — Leydig cell steroidogenesis in aging rats.

FOURTH INTERNATIONAL SYMPOSIUM, JULY 26–31, 1998.

Speakers:

  • Leonard Hayflick, Univeristy of California, San Francisco, USA — Special Lecture: How and why we age.
  • Andrzej Bartke, Southern Illinois University, USA — Does growth hormone prevent or accelerate aging?
  • Christian Behl, Max Planc Institute for Psychiatry, Germany — Effects of lgucocorticoid on exidative stree-induced hippocampal cell death: implications for the pathogenesis of Alzheimer disease.
  • Giovanni Biggio, University of Cagliari, Italy — Stress and neurosteroids in adult and aged rats.
  • Elizabeth Bock, University of Copenhagen, Denmark — Neural cell adhesion molecule [NCAM] in development and plasticity of the nervous system.
  • Othmar Gaber, University of Innsbruck, Austria — Man from Hauslabjoch.
  • Ezio Giacobini, University Hospital of Geneva University , Switzerland — Aging, Alzheimer and estrogen therapy.
  • Cheryl L. Grady, Rotman Research Insitute, Canada — Brain imaging and age-related changes in cognition.
  • Beatrix Grubeck-Loebenstein, Austrian Academy of Science, Austria — The possible role of the immune system in Alzheimer disease.
  • Joe Herbert, University of Cambridge, United Kingdom — Neurosteroids, brain damage and mental illness.
  • Karen Hsiao, University of Minnesota Medical School, USA — Transgenic mice expressing Alzheimer amyloid precursor protein.
  • Donald Ingram, National Institutes on Aging, USA — Application of gene therapy to treat age-related loss of dopamine D2 receptor.
  • S. Michal Jazwinski, Louisiana State University, USA — Genetics of longevity.
  • S.M. McCann, Pennington Biomedical Research Center, USA — Nitric oxide and aging.
  • Roberto Melcangi, University of Milan, Italy — Effects of steroid hormones on gene expression of glial markers in the central nervous system: variations induced by aging.
  • Tetsuro Miki, Osaka University Medical School, Japan — Transcriptional activation by the Werner syndrome gene product in yeast.
  • Marilyn Millter, McGill Centre for Studies on Aging, Canada — Estrogen, the ovary, and neurotransmitters: factors associated with aging.
  • Angelo Sagripanti, Institute of Clinical Medicine, Italy — Natural anticoagulants, aging and thromboembolism.
  • Stephen Sterns, University of Basel, Switzerland — The experimental evolution of aging in fruitflies.
  • Eva Syková, Charles University Institute of Experimental Medicine, Czech Republic — Diffusion contraints and neuron-glia interaction during aging.
  • F. Waldhauser, University of Vienna, Austria — Age-related changes in melatonin levels in man and their potential consequences for sleep disorders.

FIFTH INTERNATIONAL SYMPOSIUM, JULY 23–28, 2000.

Speakers:

  • Lars Bertram — Search for novel Alzheimer's disease genes – Results of the NIMH study.
  • J.M. Billard — NMDA receptor activation in aged rat hippocampus.
  • Greg Brewer — Neuronal plasticity and stressor toxicity during aging.
  • J.A. Edwardson — Multiple substrates of late-onset dementia: implications for therapy.
  • Ettore Ferrari — Pineal and adrenocortical function in physiological aging and in senile dementia.
  • Sam Gandy — Ovariectomy and 17 beta-estradiol modulate the levels of Alzheimer's amyloid beta-peptides in brain.
  • Siegfried Hoyer — Brain glucose and energy metabolism in sporadic Alzheimer disease: causes and consequences.
  • Akihisa Iguchi — The metabolism of plasma glucose and catecholamines in Alzheimer's disease.
  • P. Jansen-Dürr — Cell cycle regulation in aging.
  • Mathias Jucker — Mouse models of brain aging and Alzheimer's disease.
  • Adriana Maggi — Estrogens and apoptosis of neural cells.
  • Hari Manev — 5-Lipoxygenase and cyclooxygenase mRNA expression in rat hippocampus: early response to glutamate receptor activation by kainate.
  • Alvin M. Matsumoto — Aging and the Neuroendocrine Regulation of Reproduction and Body Weight.
  • Margaret A. Pericak-Vance — Genetics of Alzheimer disease.
  • John P. Phillips — Targeted neuronal gene expression and longevity in Drosophila.
  • Aurel Popa-Wagner — Brain plasticity: to what extent do aged animals retain the capacity to coordinate gene activity in response to acute challenges.
  • Bernard Sommer — Transgenic animals as models for degenerative diseases Mouse models of alpha-synucleinopathy and Lewy pathology.
  • A. Tatariûnas — The intrinsic fluorescence of ceroid-lipofuscin cytosomes accumulating in aging and pathology.
  • Eus J.W. Van Someren — Circadian disturbances in the elderly.
  • Johannes D. Veldhuis — Recent neuroendocrine facets of male reproductive aging: an emerging feedback-network perspective.
  • Bryant Villeponteau — Nutraceutical formulations to slow aging and treat age-related diseases.
  • Richard Weindruch — Caloric restriction and aging in rhesus monkey.
  • John Wilmoth — Demography of longevity: Past, present, and future trends.

SIXTH INTERNATIONAL SYMPOSIUM, JULY 21–26, 2002.

Speakers:

  • In Memoriam: Eduard Schönbaum 1923–2000.
  • Judith Campisi — Special Lecture: Cellular senescence and apoptosis: how cellular responses might influence aging phenotypes.
  • C. Bandtlow — Regeneration in the Central Nervous System.
  • C. Barnes — Hippocampal aging.
  • M. Gallagher — Effects of Aging on the Hippocampal Formation in a Naturally Occurring Animal Model of Mild Cognitive Impairment.
  • D. Gems — Body size, insulin/IGF signaling and ageing in the nematode Caenorhabditis elegans.
  • K. Gordon — Polycyclic phenols, estrogens and neuroprotection: A proposed mitochondrial mechanism.
  • D. Murphy — The neuroprotective effects of estrogen on the aging brain.
  • F. Lezoualc'h — Human serotonin 5-HT4 receptor and the amyloid precursor protein [APP] processing.
  • B. Lockhart — Cognition enhancing or Neuroprotective compounds for the treatment of cognitive disorders: Why? When? Which?
  • J. Macklis — Molecular Manipulation of Neural Precursors In Situ: Induction of Adult Cortical Neurogenesis.
  • J. Mattison — Caloric restriction in Rhesus monkeys.
  • F. Naftolin — Vitamin E delays the onset of hypothalamic reproductive failure in aging female rats.
  • M. Oettel — Selective aspects of endocrine pharmacology of the aging male.
  • H. Ooboshi — Brain ischemia as a potential target of gene therapy.
  • B. Pakkenberg — Aging and the human neocortex.
  • G. Paolisso — Glucose regulation and oxidative stress in healthy centenarians.
  • M. Racchi — The pharmacology of amyloid precursor protein.
  • C. Rauser — Aging, fertility and immortality.
  • D. Skene — Melatonin rhythmicity: effect of age and Alzheimer's disease.
  • J. Syka — Auditory system and aging.
  • R. Verwer — In vitro studies on adult human post mortem brain tissue in relation to aging.
  • G. Wick — A Darwinian-evolutionary concept of age-related diseases.
  • A. Wirz-Justice — Dawn-dusk Simulation Light Therapy of Disturbed Circadian Rest-activity Cycles in Demented Elderly.
  • J. Zimmerman — Nutritional control of aging.

SEVENTH INTERNATIONAL SYMPOSIUM, JULY 18–23, 2004.

Speakers:

  • C. Dominique Toran-Allerand, New York, New York, USA — Special Lecture: Estrogen and the Brain: Beyond ER-alpha and ER-beta
  • Alexander Bürkle, Konstanz, Germany — Poly ADP Ribosylation and Aging
  • Natalia Danilovich, Montreal, Canada — Role of the FSH Receptor in Reproductive Senescence and Biological Aging in Mice
  • Luis-Miguel Garcia-Segura, Madrid, Spain — Sex Hormones and Brain Aging
  • Nestor Gonzalez-Cadavid, Torrance, California, USA — Gene Therapy and Erectile Dysfunction
  • Jan-Ake Gustafsson, Huddinge, Sweden — The Role of the Estrogen Receptor Beta in Neuroprotection
  • Nobuyoshi Hirose and Toshio Kojima, Tokyo, Japan — Neurotransmitter Function in Centenarians
  • Eef Hogervorst, Oxford, UK — Testosterone and Alzheimer's Disease
  • Martin Holzenberger, Paris, France — IGF-1 Signaling and Aging
  • Xudong Huang, Charlestown, Massachusetts, USA — Novel Alzheimer's Aß Metallobiochemistry and its therapeutic implication
  • Ilpo Huhtaniemi, London, U.K. — Genetic Polymorphisms and Male Aging
  • Pidder Jansen-Dürr, Innsbruck, Austria — Oxidative Stress in Endothelial Cell Aging
  • Kay Lund, Chapel Hill, North Carolina, USA — Transcriptional Mechanisms of Hippocampal Aging and Memory Loss
  • Michal Karasek, Lodz, Poland — Melatonin, Human Aging, and Age-related Diseases
  • Mary Ann Ottinger, College Park, Maryland, USA — Reproductive Aging in Birds
  • Vladimir Patchev, Jena, Germany — Neurotropic Action of Androgens: Principles and Mechanisms
  • Thomas Perls, Boston, Massachusetts, USA — Exceptional Longevity in the Human
  • Pat Prinz, Seattle, Washington, USA — Sleep Impairments in Healthy Seniors
  • Michael Rowan, Dublin, Ireland — Mechanism of the Effects of Amyloid Beta-Protein Oligomers on Synaptic Efficacy
  • Marc Tatar, Providence, Rhode Island, USA — Endocrine Regulation of Aging in Drosophila
  • Klaus Turnheim, Vienna, Austria — Drug Therapy in the Elderly
  • Monique Vallee, Bordeaux, France — Neuroactive Steroids: New Markers of Cognitive Aging

EIGHTH INTERNATIONAL SYMPOSIUM, JULY 23–28, 2006.

Speakers:

  • Greg M. Cole, USA — Special Lecture: Insulin resistance, TZDs and aging
  • Bart Braeckman, Belgium — Genetic control of longevity in C. elegans
  • Alessandro Cellerino, Italy — Aging in a short-lived annual fish
  • Francesca Cirulli, Italy — p66Shc-/- mouse as a model to study susceptibility to stress and aging
  • Ana Maria Cuervo, USA — Alpha-synuclein and autophagy
  • Krishnan M. Dhandapani, USA — TGF-beta and neuroprotection
  • Christopher Heward, USA — Developing a SNP-based test for Alzheimer's Disease
  • Ilpo Huhtaniemi, UK — The impact of polymorphisms in genes regulating pituitary-gonadal function on gender-specific aging of European men
  • Felix Kreier, The Netherlands — Hypothalamus – leptin and hypothalamic function
  • Anthony LaMantia, USA — Neurogenesis
  • Frederic Mery, Switzerland — Trade offs in long-term memory formation
  • Alon Monsonego, Israel — Immunotherapy of Alzheimer's disease
  • Lisa Mosconi, USA — Early detection of Alzheimer's disease
  • Gerald Muench, Australia — Advanced glycation products
  • Antonio Musarò, Italy — Neuroprotective effects of a local isoform of IGF-1
  • Linda Partridge, UK — Fecundity versus longevity
  • George Roth, USA — Caloric restriction mimetics: the next phase
  • Norman Sharpless, USA — Cancer and tumor suppressors
  • Csaba Söti, Hungary — Protein toxicity and cellular defense mechanisms: the role of chaperones
  • Robert G. Struble, USA — Estrogens and glial function
  • Georg Wick, Austria — Atherosclerosis Risk-factors in Female Youngsters (ARFY) Study
  • Judy Wong, Canada — Role of Chromosome Maintenance in Human Disease and Aging

NINTH INTERNATIONAL SYMPOSIUM, JULY 20–25, 2008.

Speakers:

  • Elizabeth Blackburn, San Francisco, CA, USA — Special Lecture: Telomeres and telomerase: their implication in human age-related diseases
  • Dorothee P. Auer, Nottingham, UK — Brain imaging in Alzheimer and Parkinson's diseases
  • Nir Barzilai, Bronx, NY, USA — Central regulation of peripheral insulin action
  • Holly Brown-Borg, Grand Forks, ND, USA — Long-living growth hormone receptor knock out mice: Potential mechanisms of altered stress resistance
  • José M. Carrascosa, Madrid, Spain — Changes in the neuroendocrine control of energy homeostasis by adiposity signals during aging
  • Terry Combs, Chapel Hill, NC, USA — Neuroendocrine Inhibition of Glucose Production and Resistance to Cancer in Dwarf Mice
  • Alejandro F. De Nicola, Buenos Aires, Argentina — Steroid protection
  • Ettore Ferrari, Pavia, Italy — Pineal, adrenocortical and thyroid function in autonomous centenarians
  • Luigi Fontana, St. Louis, MO, USA & Rome, Italy — Neuroendocrine Factors in the Regulation of Inflammation: Excessive Adiposity and Calorie Restriction
  • Laura Fratiglioni, Stockholm, Sweden — Prevention of common neurodegenerative disorders in the elderly
  • Lance J. Kriegsfeld, Berkeley, CA, USA — Reproductive aging
  • Günter Lepperdinger, Innsbruck, Austria — Leptin receptor/CD295 is upregulated on primary human mesenchymal stem cells of advancing biological age and distinctly marks the subpopulation of dying cells
  • Paweł Liberski, Łódź, Poland — Kuru: its ramifications after fifty years
  • Valter D. Longo, Los Angeles, CA, USA — Linking Sirtuins, IGF-I signaling, and Starvation
  • K. Lenhard Rudolph, Ulm, Germany — Cell intrinsic and extrinsic mechanisms of stem cell aging depend on telomere status
  • Thomas Samaras, San Diego, CA, USA — The Role of Height in Human Longevity
  • Heidi Scrable, Charlottesville, VA, USA — Running on empty: how p53 controls INS/IGF signaling and affects lifespan
  • Natalie Sampson, Austrian Academy of Sciences, Austria — Integrated networks of sex steroid hormone metabolism and cytokine signalling in the pathogenesis of age-related prostatic disease
  • LaDora Thompson, Minneapolis, MN, USA — Mechanisms of sarcopenia during mammalian aging
  • Aleksandra Trifunovic, Stockholm, Sweden — Somatic mtDNA mutations and ageing – facts and fancies
  • Rudi Westendorp, Leiden, The Netherlands — The influence of age on the association between cholesterol and cognitive function

TENTH INTERNATIONAL SYMPOSIUM, JULY 25–30, 2010.

Speakers:

  • Greti Aguilera, Bethesda, MD, USA — HPA axis responsiveness to stress: Implications for ageing and well-being
  • Craig Atwood, Madison, WI, USA — Testing the Reproductive-Cell Cycle Theory of Aging
  • Andrzej Bartke, Springfield, IL, USA — Insulin signaling, calorie restriction & aging
  • Christian Benedict, Uppsala, Sweden — Intranasal Insulin: A future therapy to improve cognition in patients suffering from Alzheimer's disease?
  • Rochelle Buffenstein, San Antonio, TX, USA — Attenuated aging in the long-living naked mole-rat; endocrine and neurobiological changes
  • Rafael de Cabo, Bethesda, MD, USA — Calorie Restriction: Is It All About Appetite?
  • Monica Driscoll, Piscataway, NJ, USA — Healthspan Genetics and Tissue-specific Aspects of Age-Associated Decline: Worm Secrets for Healthy Aging
  • Ehud Cohen, Jerusalem, Israel — The insulin/IGF1 signaling pathway couples aging and neurodegeneration: from worms to mice
  • Rita Effros, Los Angeles, CA, USA — Telomere/telomerase dynamics in the immune system: effects of chronic infection and stress
  • Thomas Flatt, Vienna, Austria — Endocrine Regulation of the Trade-Off between Lifespan and Reproduction in Drosophila
  • Don Ingram, Baton Rouge, LA, USA — Glycolytic Inhibition as a Strategy for Developing Calorie Restriction Mimetics
  • Brian Kennedy, Seattle, WA, USA — Longevity pathways and Age-related disease
  • Gordon Lithgow, Novato, CA, USA — Common mechanisms of neurodegeneration and aging suggested by genes and chemical manipulation of lifespan
  • Bernd Moosmann, Mainz, Germany — Evolutionary proteomic adaptations towards longevity and stress resistance in animals
  • Marie-Christine Pardon, Nottingham, UK — Retardation of Alzheimer's-like pathology by mild stressors
  • Clemens Steegborn, Bochum, Germany — Molecular mechanisms that modulate mitochondrial lifespan regulator proteins
  • Dick Swaab, Amsterdam, Netherlands — Aging and dementia in hypothalamic systems: functional consequences
  • Ignacio Torres-Aleman, Madrid, Spain — IGF-1 in the aging brain
  • Eleni Tzima, UNC, USA — The role of hemodynamic forces in endothelial dysfunction and vascular aging
  • Alexander Vaiserman, Kiev, Ukraine — Early-life etiology of age-related diseases: epidemiological evidence
  • Holly Van Remmen, San Antonio, TX, USA — Oxidative stress induced alterations in skeletal muscle and neuromuscular junctions during aging
  • Barbara Viviani, Milan, Italy — Cytokines and neuronal channels: a molecular basis for age-related decline of neuronal function?